Research ArticleArticle
Timing and Predictors of Incident Cardiovascular Disease in Systemic Lupus Erythematosus: Risk Occurs Early and Highlights Racial Disparities
Shivani Garg, Christie M. Bartels, Gaobin Bao, Charles G. Helmick, Cristina Drenkard and S. Sam Lim
The Journal of Rheumatology August 2022, jrheum.220279; DOI: https://doi.org/10.3899/jrheum.220279
Shivani Garg
The Georgians Organized Against Lupus (GOAL) Cohort was supported by the Centers for Disease Control and Prevention (CDC; 3U58DP001487- 05W2 and U01DP05119). The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the CDC. S. Garg, MD, MS, Assistant Professor, C.M. Bartels, MD, MS, Associate Professor, Rheumatology Division, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin; G. Bao, MPH, Senior Statistician, Division of Rheumatology, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia; C.G. Helmick, MD, Professor, Division of Population Health, Centers for Disease Control and Prevention, Atlanta, Georgia; C. Drenkard, MD, PhD, Associate Professor, S.S. Lim, MD, MPH, Professor, Division of Rheumatology, Department of Medicine, Emory University School of Medicine, and Department of Epidemiology, Emory University Rollins School of Public Health, Atlanta, Georgia, USA. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. S. Garg, Rheumatology Division, Department of Medicine, University of Wisconsin School of Medicine and Public Health, 1685 Highland Ave, MFCB #4122, Madison, WI 53705, USA. Email: sgarg@medicine.wisc.edu. Accepted for publication July 20, 2022.
Christie M. Bartels
The Georgians Organized Against Lupus (GOAL) Cohort was supported by the Centers for Disease Control and Prevention (CDC; 3U58DP001487- 05W2 and U01DP05119). The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the CDC. S. Garg, MD, MS, Assistant Professor, C.M. Bartels, MD, MS, Associate Professor, Rheumatology Division, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin; G. Bao, MPH, Senior Statistician, Division of Rheumatology, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia; C.G. Helmick, MD, Professor, Division of Population Health, Centers for Disease Control and Prevention, Atlanta, Georgia; C. Drenkard, MD, PhD, Associate Professor, S.S. Lim, MD, MPH, Professor, Division of Rheumatology, Department of Medicine, Emory University School of Medicine, and Department of Epidemiology, Emory University Rollins School of Public Health, Atlanta, Georgia, USA. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. S. Garg, Rheumatology Division, Department of Medicine, University of Wisconsin School of Medicine and Public Health, 1685 Highland Ave, MFCB #4122, Madison, WI 53705, USA. Email: sgarg@medicine.wisc.edu. Accepted for publication July 20, 2022.
Gaobin Bao
The Georgians Organized Against Lupus (GOAL) Cohort was supported by the Centers for Disease Control and Prevention (CDC; 3U58DP001487- 05W2 and U01DP05119). The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the CDC. S. Garg, MD, MS, Assistant Professor, C.M. Bartels, MD, MS, Associate Professor, Rheumatology Division, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin; G. Bao, MPH, Senior Statistician, Division of Rheumatology, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia; C.G. Helmick, MD, Professor, Division of Population Health, Centers for Disease Control and Prevention, Atlanta, Georgia; C. Drenkard, MD, PhD, Associate Professor, S.S. Lim, MD, MPH, Professor, Division of Rheumatology, Department of Medicine, Emory University School of Medicine, and Department of Epidemiology, Emory University Rollins School of Public Health, Atlanta, Georgia, USA. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. S. Garg, Rheumatology Division, Department of Medicine, University of Wisconsin School of Medicine and Public Health, 1685 Highland Ave, MFCB #4122, Madison, WI 53705, USA. Email: sgarg@medicine.wisc.edu. Accepted for publication July 20, 2022.
Charles G. Helmick
The Georgians Organized Against Lupus (GOAL) Cohort was supported by the Centers for Disease Control and Prevention (CDC; 3U58DP001487- 05W2 and U01DP05119). The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the CDC. S. Garg, MD, MS, Assistant Professor, C.M. Bartels, MD, MS, Associate Professor, Rheumatology Division, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin; G. Bao, MPH, Senior Statistician, Division of Rheumatology, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia; C.G. Helmick, MD, Professor, Division of Population Health, Centers for Disease Control and Prevention, Atlanta, Georgia; C. Drenkard, MD, PhD, Associate Professor, S.S. Lim, MD, MPH, Professor, Division of Rheumatology, Department of Medicine, Emory University School of Medicine, and Department of Epidemiology, Emory University Rollins School of Public Health, Atlanta, Georgia, USA. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. S. Garg, Rheumatology Division, Department of Medicine, University of Wisconsin School of Medicine and Public Health, 1685 Highland Ave, MFCB #4122, Madison, WI 53705, USA. Email: sgarg@medicine.wisc.edu. Accepted for publication July 20, 2022.
Cristina Drenkard
The Georgians Organized Against Lupus (GOAL) Cohort was supported by the Centers for Disease Control and Prevention (CDC; 3U58DP001487- 05W2 and U01DP05119). The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the CDC. S. Garg, MD, MS, Assistant Professor, C.M. Bartels, MD, MS, Associate Professor, Rheumatology Division, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin; G. Bao, MPH, Senior Statistician, Division of Rheumatology, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia; C.G. Helmick, MD, Professor, Division of Population Health, Centers for Disease Control and Prevention, Atlanta, Georgia; C. Drenkard, MD, PhD, Associate Professor, S.S. Lim, MD, MPH, Professor, Division of Rheumatology, Department of Medicine, Emory University School of Medicine, and Department of Epidemiology, Emory University Rollins School of Public Health, Atlanta, Georgia, USA. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. S. Garg, Rheumatology Division, Department of Medicine, University of Wisconsin School of Medicine and Public Health, 1685 Highland Ave, MFCB #4122, Madison, WI 53705, USA. Email: sgarg@medicine.wisc.edu. Accepted for publication July 20, 2022.
S. Sam Lim
The Georgians Organized Against Lupus (GOAL) Cohort was supported by the Centers for Disease Control and Prevention (CDC; 3U58DP001487- 05W2 and U01DP05119). The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the CDC. S. Garg, MD, MS, Assistant Professor, C.M. Bartels, MD, MS, Associate Professor, Rheumatology Division, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin; G. Bao, MPH, Senior Statistician, Division of Rheumatology, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia; C.G. Helmick, MD, Professor, Division of Population Health, Centers for Disease Control and Prevention, Atlanta, Georgia; C. Drenkard, MD, PhD, Associate Professor, S.S. Lim, MD, MPH, Professor, Division of Rheumatology, Department of Medicine, Emory University School of Medicine, and Department of Epidemiology, Emory University Rollins School of Public Health, Atlanta, Georgia, USA. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. S. Garg, Rheumatology Division, Department of Medicine, University of Wisconsin School of Medicine and Public Health, 1685 Highland Ave, MFCB #4122, Madison, WI 53705, USA. Email: sgarg@medicine.wisc.edu. Accepted for publication July 20, 2022.

Published eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Jump to comment:
No eLetters have been published for this article.
In this issue
The Journal of Rheumatology
Vol. 50, Issue 3
1 Mar 2023
Timing and Predictors of Incident Cardiovascular Disease in Systemic Lupus Erythematosus: Risk Occurs Early and Highlights Racial Disparities
Shivani Garg, Christie M. Bartels, Gaobin Bao, Charles G. Helmick, Cristina Drenkard, S. Sam Lim
The Journal of Rheumatology Aug 2022, jrheum.220279; DOI: 10.3899/jrheum.220279
Timing and Predictors of Incident Cardiovascular Disease in Systemic Lupus Erythematosus: Risk Occurs Early and Highlights Racial Disparities
Shivani Garg, Christie M. Bartels, Gaobin Bao, Charles G. Helmick, Cristina Drenkard, S. Sam Lim
The Journal of Rheumatology Aug 2022, jrheum.220279; DOI: 10.3899/jrheum.220279